Search Within

Thoracic Oncology

  1. "Cancer"
Formats
  1. Journal Article (37)
  2. Review (4)
  3. Conference Paper (2)
Groups
  1. Department of Medicine (43)
  2. Solid Tumor Oncology Division (43)
  3. Nursing (16)
  4. Biostatistics Service (10)
  5. Epidemiology and Biostatistics (10)
  6. Department of Pathology and Laboratory Medicine (7)

More Groups

People
  1. Mark Kris (33)
  2. Leslie Tyson (11)
  3. Vincent Miller (10)
  4. Gregory Riely (9)
  5. Alexander Drilon (7)
  6. Katherine Pisters (7)

More People

Years
  1. 2025 (3)
  2. 2023 (1)
  3. 2020 (2)
  4. 2019 (1)
  5. 2018 (2)
  6. 2017 (1)

More Years

Publications
  1. Cancer (43)
Publishers
  1. Wiley Blackwell (43)

Results (43)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Targeting ROS1 rearrangements in non–small cell lung cancer: Current insights and future directions
    Review

    Desilets, A.; Repetto, M.; Yang, S. R.; Drilon, A.
    Cancer (2025)

    Fulltext@MSK | Save
  • From knowledge to action: The journey toward targeting the MET pathway via MET exon 14 skipping
    Review

    Bogdanska, W.; Paik, P. K.
    Cancer (2025)

    Fulltext@MSK | Save
  • Targeting HER2 in lung cancers: Evolving treatment landscape and drug development strategies
    Review

    Reinhorn, D.; Moskovitz, M.; Tap, W. D.; Li, B. T.
    Cancer (2025)

    Fulltext@MSK | Save
  • Larotrectinib efficacy and safety in adult patients with tropomyosin receptor kinase fusion sarcomas
    Journal Article

    Kummar, S.; Shen, L.; Hong, D. S.; McDermott, R.; Keedy, V. L.; Casanova, M.; Demetri, G. D.; Dowlati, A.; Melcón, S. G.; Lassen, U. N.; more...
    Cancer (2023)

    Fulltext@MSK | Save
  • Clinical implications of drug-induced liver injury in early-phase oncology clinical trials
    Journal Article

    Mondaca, S. P.; Liu, D.; Flynn, J. R.; Badson, S.; Hamaway, S.; Gounder, M. M.; Khalil, D. N.; Drilon, A. E.; Li, B. T.; Jhaveri, K. L.; more...
    Cancer (2020)

    Fulltext@MSK | Save
  • The METeoric rise of MET in lung cancer
    Review

    Friedlaender, A.; Drilon, A.; Banna, G. L.; Peters, S.; Addeo, A.
    Cancer (2020)

    Fulltext@MSK | Save
  • Frequency and outcomes of brain metastases in patients with HER2-mutant lung cancers
    Journal Article

    Offin, M.; Feldman, D.; Ni, A.; Myers, M. L.; Lai, W. V.; Pentsova, E.; Boire, A.; Daras, M.; Jordan, E. J.; Solit, D. B.; more...
    Cancer (2019)

    Fulltext@MSK | Save
  • Improving therapy for patients with epidermal growth factor receptor-mutant lung cancer
    Journal Article

    Arbour, K. C.; Riely, G. J.
    Cancer (2018)

    Fulltext@MSK | Save
  • Twice weekly pulse and daily continuous-dose erlotinib as initial treatment for patients with epidermal growth factor receptor–mutant lung cancers and brain metastases
    Journal Article

    Arbour, K. C.; Kris, M. G.; Riely, G. J.; Ni, A.; Beal, K.; Daras, M.; Hayes, S. A.; Young, R. J.; Rodriguez, C. R.; Ahn, L.; more...
    Cancer (2018)

    Fulltext@MSK | Save
  • HER2 mutations in lung adenocarcinomas: A report from the Lung Cancer Mutation Consortium
    Journal Article

    Pillai, R. N.; Behera, M.; Berry, L. D.; Rossi, M. R.; Kris, M. G.; Johnson, B. E.; Bunn, P. A.; Ramalingam, S. S.; Khuri, F. R.
    Cancer (2017)

    Fulltext@MSK | Save